New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
09:18 EDTQIWI, FST, MDT, EXPE, PGEM, ANFI, HIMX, DSW, GALE, YGE, NUANOn The Fly: Pre-market Movers
HIGHER: Amira Nature Foods (ANFI), up 30% after Q4 results top expectations... DSW (DSW), up 2.6% after upgraded at Goldman... Yingli Green Energy (YGE), up 3.4% after reaffirming its FY14 PVmodule shipment target... Nuance (NUAN), up 3% after WSJ reported yesterday that the company is looking into potential sale, Oppenheimer estimates that Nuance could be sold for $25-$30... Medtronic (MDT), up 2.8% after upgrades at Morgan Stanley, Credit Suisse, and RBC Capital... Forest Oil (FST), up 15% after Sabine Oil & Gas denies $850M bridge financing facility was pulled... Galena (GALE), up 5% after completing enrollment in GALE-301 Phase 2a trial... Expedia (EXPE), up 2.6% following upgrade at Susquehanna. LOWER: Ply Gem (PGEM), down 5.8% after downgraded at Goldman... Himax (HIMX), down 4.4% after downgraded at UBS... QIWI (QIWI), down 3.6% after 7.973M share Secondary priced at $40.00.
News For DSW;EXPE;NUAN;HIMX;MDT;YGE;ANFI;FST;GALE;PGEM;QIWI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 17, 2015
07:01 EDTDSWDSW reports Q4 adjusted EPS 35c, consensus 28c
Subscribe for More Information
March 16, 2015
15:26 EDTDSWNotable companies reporting before tomorrow's open
Subscribe for More Information
14:43 EDTHIMXAnalyst sees Himax facing headwinds, risks in near-term
The shares of Himax Technologies (HIMX) are falling sharply after research firm Northland Securities warned that the company's March revenues could come in at the lower end of its guidance. Himax develops semiconductors used in thin film transistor-liquid crystal displays and displays using other technologies. WHAT'S NEW: The Chinese sales of smartphones made by a number of Himax's customers, including Samsung, Lenovo (LNVGY), and ZTE, have been weak, Northland analyst Tom Sepenzis wrote in a note to investors today. Additionally, Samsung's new smartphones will probably ship with OLED displays, rather than TFT displays, the analyst stated. These developments create risks for Himax in the March-June time period, according to Sepenzis. Meanwhile, January and February data reported by a number of Taiwanese vendors, including HTC and Taiwan Semiconductor (TSM), do not bode well for Himax, as their sales were down 26.5% in February versus January. Additionally, Sepenzis is now more pessimistic on the near-term outlook for sales of augmented reality headsets, leading him to believe that Himax's revenue from these products will be lower than he previously estimated in the near-term. The analyst kept a $110 price target and Outperform rating on the shares, as he remains upbeat on the company's longer term outlook. PRICE ACTION: In mid-afternoon trading, Himax dropped 51c, or 6.5% to $7.47.
13:16 EDTMDTAnalysts upbeat on results of Edwards' Sapien 3 data
The shares of Edwards Lifesciences (EW) are rising after the company released data on its Sapien 3 transcathter aortic valve over the weekend. In notes to investors today, a number of analysts were upbeat on the data. BACKGROUND: Edwards yesterday announced that high- and intermediate-risk patients treated with Sapien 3 demonstrated lower mortality rates than patients treated with previous transcathter aortic valves, or TAVR, made by the company. The patients also had excellent clinical outcomes in the other primary endpoints of stroke and paravalvular regurgitation, the company stated. Meanwhile, a five year study of patients treated with the first generation SAPIEN device showed that the patients had equivalent outcomes to traditional open-heart surgery, and no structural valve deterioration requiring intervention, the company stated. ANALYST REACTION: Edwards' Sapien 3 data was impressive, as the device showed one of the lowest stroke and mortality rates of any major TAVR study so far, Bernstein analyst Derrick Sung wrote in a note to investors earlier today. Data presented by Edwards and other companies at the American College of Cardiology, or ACC, conference this weekend caused investors and the medical community to become more optimistic about the potential for TAVR devices to replace surgical valves, Sung stated. The analyst wrote that he continues to believe that investors are underestimating the potential size of the TAVR market. Also upbeat on Edwards' data was Wells Fargo, which wrote that the data exceeded high expectations and could pressure the FDA to approve Sapien 3 for intermediate risk patients earlier than Edwards' guidance of late 2016. WHAT'S NOTABLE: Analysts were also upbeat on data reported by other companies at the ACC conference. Medtronic's (MDT) data suggested that its CoreValve Evolut-R product may be as effective as Edwards' Sapien 3, Bernstein's Sung stated. The FDA appears to have allowed Boston Scientific's (BSX) left atrial appendage closure, Watchman, to be provided to more patients than expected, research firm Stifel believes. Meanwhile, St. Jude's (STJ) CardioMEMS device yielded "impressive" mortality data, the firm added. Stifel kept Buy ratings on both Medtronic and St. Jude. PRICE ACTION: In early afternoon trading, Edwards Lifesciences climbed 9% to $147.64, Boston Scientific advanced 4% to $17.27, St. Jude added 2% to $67.55, and Medtronic rose 1.3% to $77.50.
12:59 EDTDSWDSW March volatility increases into Q4 and outlook
Subscribe for More Information
11:14 EDTHIMXHimax China sales falling, estimates need to come down, says Northland
Subscribe for More Information
07:30 EDTMDTAmerican College of Cardiology to hold an expo
Subscribe for More Information
07:22 EDTMDTMedtronic Edwards Lifesciences data 'impressive,' says Bernstein
Subscribe for More Information
06:11 EDTYGEYingli Green Energy begins construction of 50 MW plant in Hubei Province
Yingli Green Energy announced that it has begun construction of a 50 MW solar power plant on former mining lands in in Huangshi City, Hubei Province, China. It is the first project developed by Yingli on land that has been degraded by mining activities. The 50 MW power plant occupies over 100 hectares of land in western Huangshi City, a region known for its rich mineral resources and extensive mining operations. The project will contain about 170,000 YGE 72 Cell Series multicrystalline solar panels that are expected to generate approximately 55,000 megawatt-hours of clean electricity annually, which will offset the consumption of nearly 22,000 tons of coal and the emission of over 50,000 tons of carbon into the atmosphere. The system is scheduled to interconnect with the local utility grid and begin operations in Q4.
March 15, 2015
15:27 EDTMDTMedtronic unveils data from high risk study of the CoreValve U.S. pivotal trial
Subscribe for More Information
15:23 EDTMDTMedtronic unveils preclinical outcomes of its novel Drug-Filled Stent
Subscribe for More Information
15:20 EDTMDTMedtronic announces outcomes for its next-generation CoreValve Evolut R System
Medtronic announced initial clinical outcomes for its next-generation CoreValve Evolut R System. At 30-days, the new recapturable, self-expanding valve showed no incidents of all-cause mortality or stroke in a high and extreme risk patient population. Data from the Evolut R Study, which enrolled 60 patients from six centers in the United Kingdom, Australia and New Zealand, were unveiled today at the 64th Annual Scientific Session of the American College of Cardiology. The CoreValve Evolut R System is not approved for commercial use in the United States where it is currently undergoing clinical trials. "Initial clinical experience with the Evolut R system is remarkable and ushers in a new era of TAVR technology that provides increased confidence with recapturability, excellent procedural results, and impressive clinical outcomes," said Ian Meredith, M.D., of Monash Heart - Monash Health, Melbourne, Australia, who is one of the investigators of the study. "The 14 French equivalent delivery system allowed transfemoral access for most patients and the recapturable technology enabled implanters to optimize valve placement for improved annular sealing and reduced conduction disturbances without compromise on mortality or stroke."
March 13, 2015
11:58 EDTDSWDSW March volatility elevated into Q4 and outlook
DSW March call option implied volatility is at 74, April is at 41, July is at 32; compared to its 26-week average of 33 according to Track Data, suggesting large near term price movement into the expected release of Q4 results on March 17.
10:09 EDTGALEHigh option volume stocks
High option volume stocks: ULTA HOG CTIC CTL LOCO IMPV BMRN IMOS ATHX GALE
10:00 EDTQIWIOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Aramark (ARMK) downgraded to Neutral from Outperform at RW Baird... Broadcom (BRCM) downgraded to Hold from Buy at Canaccord... Children's Place (PLCE) downgraded to Neutral from Buy at Citigroup... Depomed (DEPO) downgraded to Hold from Buy at WallachBeth... Diageo (DEO) downgraded to Underperform from Neutral at Credit Suisse... DreamWorks (DWA) downgraded to Neutral from Buy at B. Riley... Gaming and Leisure Properties (GLPI) downgraded to Neutral at Susquehanna... Genesco (GCO) downgraded at Sterne Agee... Host Hotels (HST) downgraded to Underperform from Market Perform at Raymond James... InspireMD (NSPR) downgraded at Oppenheimer... Integrated Silicon (ISSI) downgraded to Neutral from Buy at B. Riley... InterXion (INXN) downgraded to Market Perform from Outperform at Raymond James... JG Wentworth (JGW) downgraded to Hold from Buy at Jefferies... Lumber Liquidators (LL) downgraded to Neutral from Buy at Goldman... QIWI (QIWI) downgraded to Neutral at Susquehanna... Regional Management (RM) downgraded to Underperform from Neutral at Macquarie... Royal Dutch Shell (RDS.A) downgraded to Sector Perform from Outperform at RBC Capital... Rudolph Technologies (RTEC) downgraded to Neutral from Buy at DA Davidson.
09:25 EDTGALEOn The Fly: Pre-market Movers
UP AFTER EARNINGS: FXCM (FXCM), up 15.8%... El Pollo LoCo (LOCO), up 9.9%... Ulta Salon (ULTA), up 7.1%... Hibbett Sports (HIBB), up 5.1%... Ann Inc (ANN), up 5.5%... Spectrum Pharmaceuticals (SPPI), up 2.9%. ALSO HIGHER: Herbalife (HLF), up 5.1% following a Wall Street Journal report that federal prosecutors are investigating potential stock manipulation... Mobileye (MBLY), up 4.7% after being upgraded at Goldman... NXP Semiconductors (NXPI), up 1.7% after being initiated with a Strong Buy at Needham. DOWN AFTER EARNINGS: Aeropostale (ARO), down 13.2%... CTI BioPharma (CTIC), down 7.7%... Civeo (CVEO), down 3.4%. ALSO LOWER: Galena Biopharma (GALE), down 10.4% after announcing public offering of common stock and warrants... Whiting Petroleum (WLL), down 7.6% following a report from Reuters that explains that the company looks to sell certain assets instead of the whole company... Continental Building (CBPX), down 7.5% after 5M share Spot Secondary priced at $19.70.
09:24 EDTGALEGalena Biopharma 24.359M share Spot Secondary priced at $1.56
Subscribe for More Information
08:34 EDTNUANNuance management to meet with FBR Capital
Meetings to be held in Seattle and Portland on March 17 hosted by FBR Capital.
07:17 EDTQIWIQIWI downgraded to Neutral at Susquehanna
Subscribe for More Information
06:47 EDTQIWIQIWI downgraded to Neutral from Positive at Susquehanna
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use